2.Sanchez-Barriga, JJ (2015) Mortality trends and risk of dying from pulmonary tuberculosis in the 7 socioeconomic regions and the 32 States of Mexico, 2000–2009. Archivos de Bronconeumología 51, 16–23.
5.Najera-Ortiz, JC et al. (2008) Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico. International Journal of Epidemiology 37, 786–795.
7.Restrepo, BI et al. (2011) Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bulletin of the World Health Organization 89, 352–359.
8.Perez-Navarro, LM et al. (2017) The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis (Edinb) 103, 83–91.
9.Delgado-Sanchez, G et al. (2015) Association of pulmonary tuberculosis and diabetes in Mexico: analysis of the national tuberculosis registry 2000–2012. PLoS ONE 10, e0129312.
10.Viswanathan, V et al. (2014) Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis – a report from South India. Journal of Diabetes Complications 28, 162–165.
11.Chaudhry, LA et al. (2012) Prevalence of diabetes type-2 and pulmonary tuberculosis among Filipino and treatment outcomes: a surveillance study in the Eastern Saudi Arabia. International Journal of Mycobacteriology 1, 106–109.
12.Dooley, KE et al. (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. American Journal of Tropical Medicine and Hygiene 80, 634–639.
13.Jimenez-Corona, ME et al. (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68, 214–220.
14.Mi, F et al. (2013) Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China. Tropical Medicine and International Health 18, 1379–1385.
15.Perez-Navarro, LM, Fuentes-Dominguez, FJ and Zenteno-Cuevas, R (2015) Type 2 diabetes mellitus and its influence in the development of multidrug resistance tuberculosis in patients from southeastern Mexico. Journal of Diabetes Complications 29, 77–82.
16.Ponce-De-Leon, A et al. (2004) Tuberculosis and diabetes in Southern Mexico. Diabetes Care 27, 1584–1590.
17.Abdelbary, BE et al. (2016) Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico. Tuberculosis (Edinb) 101S, S124–S134.
18.Nissapatorn, V et al. (2005) Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian Journal of Tropical Medicine and Public Health 36 (suppl. 4), 213–220.
19.Hernández-Ávila, MG, Gutierrez, JP and Reynoso-Noverón, N (2013) Diabetes mellitus in Mexico: status of the epidemic. Salud Publica México 55, s129.
20.Lonnroth, K et al. (2010) A consistent log-linear relationship between tuberculosis incidence and body mass index. International Journal of Epidemiology 39, 149–155.
22.Bhargava, A et al. (2013) Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS ONE 8, e77979.
23.Lai, H-H, Lai, Y-J and Yen, Y-F (2017) Association of body mass index with timing of death during tuberculosis treatment. PLoS ONE 12, e0170104.
24.Najera-Ortiz, JC et al. (2012) The poor survival among pulmonary tuberculosis patients in Chiapas, Mexico: the case of Los Altos region. Tuberculosis Research and Treatment 2012, 708423.
26.Tollefson, D et al. (2013) Burden of tuberculosis in indigenous peoples globally: a systematic review. International Journal of Tuberculosis and Lung Disease 17, 1139–1150.
27.Sanchez-Perez, HJ et al. (2002) Detection of pulmonary tuberculosis in Chiapas, Mexico. Annals of Epidemiology 12, 166–172.
28.Sánchez-Pérez, HJ et al. (2015) Tuberculosis (TB) and human rights in Chiapas, Mexico. In Ribon, W (ed.) Tuberculosis – Expanding Knowledge. Rijeka: InTech, pp. Ch. 01.
29.Excluded people, eroded communities: Realizing the right to health in Chiapas, Mexico (2006) El Colegio de la Frontera Sur; Centro de Capacitación en Ecología y Salud para Campesions-Defensoria del Derecho a la Salud. Physicians for Human Rights (Publisher). Available at https://s3.amazonaws.com/PHR_Reports/excluded-people-eroded.pdf.
30.Alvarez, G et al. (2011) SP5-4 An ecosocial assessment of tuberculosis among Mexican migrants indigenes in Sonora, Mexico. Journal of Epidemiology and Community Health 65(suppl. 1), A446-A446.
31.Lara-Riegos, JC et al. (2015) Diabetes susceptibility in Mayas: evidence for the involvement of polymorphisms in HHEX, HNF4alpha, KCNJ11, PPARgamma, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes. Gene 565, 68–75.
34.Rendon, A et al. (2018) Migration, TB control and elimination: whom to screen and treat. Pulmonology 24, 99–105.
35.Girardi, E et al. (2017) The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. International Journal of Infectious Diseases 56, 45–53.
39.Restrepo, BI and Schlesinger, LS (2014) Impact of diabetes on the natural history of tuberculosis. Diabetes Research and Clinical Practice 106, 191–199.
40.Workneh, MH, Bjune, GA and Yimer, SA (2017) Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS ONE 12, e0175925.
41.Restrepo, BI et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection 135, 483–491.
42.Castellanos-Joya, M et al. (2014) Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS ONE 9, e106961.
45.De Maayer, T and Saloojee, H (2011) Clinical outcomes of severe malnutrition in a high tuberculosis and HIV setting. Archives of Disease in Childhood 96, 560–564.
46.Baker, MA et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 9, 81.
47.Al-Rifai, RH et al. (2017) Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS ONE 12, e0187967.
48.Huangfu, P et al. (2017) Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis. International Journal of Tuberculosis and Lung Disease 21, 1214–1219.
49.Critchley, JA et al. (2017) Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest 152, 165–173.
50.Prada-Medina, CA et al. (2017) Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications. Scientific Reports 7, 1999.
51.Restrepo, BI et al. (2018) Diabetes screen during tuberculosis contact investigations highlights opportunity for diabetes diagnosis and reveals metabolic differences between ethnic groups. Tuberculosis (Edinb) 113, 10–18.
52.Lee, PH et al. (2014) Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS ONE 9, e92623.
56.Sanchez-Perez, HJ et al. (2010) Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico. International Journal of Tuberculosis and Lung Disease 14, 34–39.
57.Leung, CC et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. American Journal of Epidemiology 167, 1486–1494.